SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-20-019026
Filing Date
2020-04-28
Accepted
2020-04-28 09:18:25
Documents
19
Period of Report
2020-06-23
Effectiveness Date
2020-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A eypt-def14a_20200623.htm DEF 14A 1179256
2 GRAPHIC goifj1zgmhv2000014.jpg GRAPHIC 10344
3 GRAPHIC goifj1zgmhv2000006.jpg GRAPHIC 12828
4 GRAPHIC goifj1zgmhv2000007.jpg GRAPHIC 9712
5 GRAPHIC goifj1zgmhv2000012.jpg GRAPHIC 2533
6 GRAPHIC goifj1zgmhv2000002.jpg GRAPHIC 2933
7 GRAPHIC goifj1zgmhv2000008.jpg GRAPHIC 1665
8 GRAPHIC goifj1zgmhv2000001.jpg GRAPHIC 4729
9 GRAPHIC goifj1zgmhv2000010.jpg GRAPHIC 1053
10 GRAPHIC goifj1zgmhv2000013.jpg GRAPHIC 815
11 GRAPHIC goifj1zgmhv2000017.jpg GRAPHIC 815
12 GRAPHIC goifj1zgmhv2000018.jpg GRAPHIC 815
13 GRAPHIC goifj1zgmhv2000003.jpg GRAPHIC 4729
14 GRAPHIC goifj1zgmhv2000015.jpg GRAPHIC 1457
15 GRAPHIC goifj1zgmhv2000005.jpg GRAPHIC 4729
16 GRAPHIC goifj1zgmhv2000016.jpg GRAPHIC 1471
17 GRAPHIC goifj1zgmhv2000011.jpg GRAPHIC 1413
18 GRAPHIC goifj1zgmhv2000009.jpg GRAPHIC 1011
19 GRAPHIC goifj1zgmhv2000004.jpg GRAPHIC 3040
  Complete submission text file 0001564590-20-019026.txt   1274375
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-51122 | Film No.: 20822596
SIC: 3826 Laboratory Analytical Instruments
Office of Life Sciences